Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-Q, Date: 2016-08-04, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CBPO/20160804/10-Q/1/000.htm SEC Original: v444649_10q.htm

---

---

Webplus: CBPO/20160804/10-Q/2_EX-3.1/000.htm SEC Original: v444649_ex3-1.htm
STATE OF DELAWARE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State

---

---

Webplus: CBPO/20160804/10-Q/3_EX-10.1/000.htm SEC Original: v444649_ex10-1.htm
Settlement Agreement This settlement agreement (this “Agreement”) was entered into by and among the following parties (the “Parties,” and each a “Party”) in Yunyan District, Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. Party B: Guiyang Dalin Biologic Technologies Co., Ltd. Party C: Guizhou Jie’an Company Party D: Shenzhen Yigong Shengda Technology Co.,

---

---

Webplus: CBPO/20160804/10-Q/4_EX-10.2/000.htm SEC Original: v444649_ex10-2.htm
Guarantee Agreement This Guarantee Agreement (this “Agreement”) was entered into by the following parties (the “Parties,” and each a “Party”) at No.808 Meeting Room No. 3 Office Building of Guizhou Province Government in Guiyang City, China on July 31, 2016: Party A: Guizhou Taibang Biological Products Co., Ltd. (“Guizhou Taibang”) Party B: Guiyang Dalin Biologic Technologies Co., Ltd. (“Guiyang Dalin”)

---

---

Webplus: CBPO/20160804/10-Q/5_EX-10.3/000.htm SEC Original: v444649_ex10-3.htm
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of this July 1, 2016 (the “Effective Date”) by and between CHINA BIOLOGIC PRODUCTS, INC., a Delaware corporation (the “Company”) and Mr. Hui (David) Li (hereinafter referred to as the “Consultant”). WHEREAS, NOW, THEREFORE, Senior Strategic and Investment Consulting Agreement 1. provided however Term 2. Compensation 3. (c) Consultant

---

---

Webplus: CBPO/20160804/10-Q/6_EX-10.4/000.htm SEC Original: v444649_ex10-4.htm
Second Amended and Restated Employment Agreement Agreement Company Executive This Second Amended and Restated Employment Agreement (this “ 2012 Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ 2014 Agreement WHEREAS, the Company and the Executive entered into a renewal employment agreement dated as of May 11, 2014 (the

---

---

Webplus: CBPO/20160804/10-Q/7_EX-31.1/000.htm SEC Original: v444649_ex31-1.htm
CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: CBPO/20160804/10-Q/8_EX-31.2/000.htm SEC Original: v444649_ex31-2.htm
CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CBPO/20160804/10-Q/9_EX-32.1/000.htm SEC Original: v444649_ex32-1.htm
2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer

---

---

Webplus: CBPO/20160804/10-Q/10_EX-32.2/000.htm SEC Original: v444649_ex32-2.htm
2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer) Chief Financial Officer

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-Q, Date: 2016-08-04, XBRL Interactive FinancialsCIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125